Legal and policy challenges to pharmaceutical regulation
Work-in-progress seminar
This seminar addresses pressing challenges facing pharmaceutical regulation. First, the growing acknowledgement of patient-centered pharmaceutical care raises questions for many regulators about how to safeguard the independence of regulators, and the rigor and representativeness of clinical and other data they use in the process. This seminar examines questions about regulatory decision making that appropriately takes account of patients, their preferences, their (unmet) needs, and their (real world) data. Second, globalization and regionalization position the EU and its regulator, the European Medicines Agency, as influential actors in the governance of pharmaceutical safety and efficacy worldwide. This seminar focuses on ongoing research into the EU’s impact on pharmaceutical regulation in low- and middle-income countries.
Event details from: Legal and policy challenges to pharmaceutical regulation
- Date
- 9 January 2024
- Time
- 09:30 – 13:00
- Room
- A3.01
This seminar brings together ongoing or recently completed research on legal and policy aspects of regulatory decision making that are relevant for multiple jurisdictions. It is part of the NWO veni project Global Access to Medicines through EU Law & Policy.
Registration (free of charge) is required for this in-person event.
Programme
9:30 Round of introductions
Patient stories in regulatory decision making
Dr. Tineke Kleinhout-Vliek, Utrecht University
Representing patient interests in public policy: Is industry funding a concern?
Prof. Barbara Mintzes PhD, University of Sydney
Lex Sex – Regulatory perspectives on women in clinical trials
Dr. Jakob Wested, University of Copenhagen/Danish Medicines Agency
10:45-11:00 Break
EMA and FDA use of Real World Data: comparing the data and definitions
Kaat van Delm LLM, KU Leuven
Are innovative medicines authorized by the EU also approved in developing countries?
Dr. Katrina Perehudoff and Majd Alshoufi BPharm MSc, University of Amsterdam
External trust in the EMA: Implications for access to vaccines in Least Developed Countries
Pramiti Parwani LLM, University of Amsterdam
Patient safety in low- and middle-income countries: the role of EMA advice to withdraw medicines
Séraphine Bruinsma BSc, Vrije Universiteit Amsterdam
12:00-13:00 Lunch (provided)